Actionable news
All posts from Actionable news
Actionable news in LGND: Ligand Pharmaceuticals Incorporated,

Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q3 2015 Results - Earnings Call Transcript


Welcome to the Ligand Pharmaceuticals' Third Quarter 2015 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to your host, Todd Pettingill, Senior Manager of Corp Development. Thank you, sir. You may begin.

Todd Pettingill - Senior Manager, Corp Dev and IR

Well Ligand Pharmaceuticals third quarter financial results for 2015 and business update conference call. Speaking today for Ligand are John Higgins, CEO, Matt Foehr, President and COO and Matt Korenberg, CFO. As a reminder today' call will contain forward-looking statements within the meaning of Federal Securities Laws. These may include but are not limited to statements regarding intents, belief or current expectations of the company, its internal and partner licensed and other programs including Promacta and Kyprolis and it's management. These statements involve risks and uncertainties and actual events or results may differ materially from the projections described in today's press release and this conference call. Additional information...